Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.62 |
| ▸ | GAA | P10253 | 1/20 | 0.62 |
| ▸ | HPGD | P15428 | 1/20 | 0.62 |
| ▸ | KAT6A | Q92794 | 12/20 | 0.53 |
| ▸ | RAB9A | P51151 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.48 |
| ▸ | LARS1 | Q9P2J5 | 1/20 | 0.47 |
| ▸ | BCAT1 | P54687 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3142366 | 0.88 | ALDH1A1 (0.66) | ALDH1A1GAAHPGDRAB9AKMT2A | |
| SCHEMBL3171214 | 0.84 | ALDH1A1 (0.71) | ALDH1A1GAAHPGDKAT6ARAB9A | |
| SCHEMBL3147276 | 0.81 | KAT6A (0.58) | ALDH1A1GAAHPGDKAT6ARAB9A | |
| SCHEMBL13954376 | 0.75 | LARS1 (0.60) | KAT6ALARS1 | |
| SCHEMBL28676609 | 0.75 | ALDH1A1 (0.85) | ALDH1A1GAAHPGDRAB9AKMT2A | |
| SCHEMBL20233085 | 0.75 | KAT6A (0.83) | GAAKAT6AKMT2A | |
| SCHEMBL14865509 | 0.73 | ALDH1A1 (0.63) | ALDH1A1GAAHPGDRAB9A | |
| SCHEMBL5183973 | 0.72 | KAT6A (0.56) | ALDH1A1GAAKAT6AKMT2APOLB | |
| SCHEMBL7449510 | 0.71 | ALDH1A1 (0.52) | ALDH1A1GAAKAT6ARAB9AKMT2A | |
| SCHEMBL28692846 | 0.71 | ALDH1A1 (0.88) | ALDH1A1GAAHPGDRAB9AKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100004339-A1 | Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists | OY JUVANTIA PHARMA LTD. (FI) | 2010-01-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100004339-A1 | Somatostatin Receptor 1 and/or 4 Selective Agonists and Antagonists | SSTR4, SSTR1, SSTR3 | ALDH1A1 4124/4885GAA 2847/4885HPGD 4435/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.